Rani Therapeutics Holdings, Inc.
RANI- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001856725
In the last 90 days, Rani Therapeutics Holdings, Inc. insiders filed 2 open-market purchases and 2 sales; 68 institutions reported holding it in 13F filings for Q2 2026, worth $34.7M in total; no superinvestor holds it.
Q3 2022 vs. Q2 2022
How the institutions holding Rani Therapeutics Holdings, Inc. changed between Q2 2022 and Q3 2022.
All holders in Q3 2022All holders in Q2 2022
| Measure | Q2 2022 | Of which not filed for Q3 2022 | Q3 2022 | Change |
|---|---|---|---|---|
| Holders | 28 | 1 | 32 | +5 |
| Shares | 2.83M | 14.3K | 3.17M | +363.8K (+12.9%) |
| Value | $29.1M | $148.0K | $30.4M | +$1.46M (+5.0%) |
1 institution that held it in Q2 2022 haven't filed for Q3 2022 yet. Not filing isn't selling, so the changes leave them out.
New holders (7)
Institutions that held Rani Therapeutics Holdings, Inc. at the end of Q3 2022 but not at the end of Q2 2022.
| Institution | Shares | Value | % of portfolio |
|---|---|---|---|
| Motco | 48,129 | $461.0K | 0.04% |
| Lafayette Investments, Inc. | 19,893 | $191.0K | 0.06% |
| Iowa State Bank | 18,862 | $181.0K | 0.05% |
| Jacobs Levy Equity Management, Inc | 18,712 | $179.0K | 0.00% |
| Simplex Trading, LLC | 222 | $2.00K | 0.00% |
| China Universal Asset Management Co., Ltd. | 229 | $2.00K | 0.00% |
| BNP Paribas Arbitrage, SA | 151 | $1.45K | 0.00% |
Sold out (2)
Institutions that held Rani Therapeutics Holdings, Inc. at the end of Q2 2022 and filed for Q3 2022 without it.
| Institution | Shares, Q2 2022 | Value, Q2 2022 |
|---|---|---|
| Advisor Group Holdings, Inc. | 19,012 | $196.0K |
| Goldman Sachs Group Inc | 10,739 | $111.0K |
Not filed for Q3 2022 yet (1)
Institutions that held Rani Therapeutics Holdings, Inc. at the end of Q2 2022 and haven't filed a 13F for Q3 2022. Not filing isn't selling, so they aren't counted as sold out.
| Institution | Shares, Q2 2022 | Value, Q2 2022 |
|---|---|---|
| Crossvault Capital Management LLC | 14,285 | $148.0K |